BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 24393575)

  • 21. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
    Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
    Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of complications after percutaneous coronary interventions with statins].
    Mega S; Nusca A; Patti G
    Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.
    Kim JH; Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC
    Am J Cardiol; 2014 Dec; 114(12):1830-5. PubMed ID: 25438909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and validation of a pre-percutaneous coronary intervention risk model of contrast-induced acute kidney injury with an integer scoring system.
    Inohara T; Kohsaka S; Abe T; Miyata H; Numasawa Y; Ueda I; Nishi Y; Naito K; Shibata M; Hayashida K; Maekawa Y; Kawamura A; Sato Y; Fukuda K
    Am J Cardiol; 2015 Jun; 115(12):1636-42. PubMed ID: 25891989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Ocek AH; Celik IE; Kilic A; Koseoglu C; Oksuz F; Baris VO
    Angiology; 2015 Nov; 66(10):957-63. PubMed ID: 25688117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
    Guo W; Liu Y; Chen JY; Chen SQ; Li HL; Duan CY; Liu YH; Tan N
    Angiology; 2015 Sep; 66(8):721-6. PubMed ID: 25616679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions.
    Khanal S; Attallah N; Smith DE; Kline-Rogers E; Share D; O'Donnell MJ; Moscucci M
    Am J Med; 2005 Aug; 118(8):843-9. PubMed ID: 16084176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.
    Peguero JG; Cornielle V; Gomez SI; Issa OM; Heimowitz TB; Santana O; Goldszer RC; Lamas GA
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):310-4. PubMed ID: 24367008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention.
    Sato A; Hoshi T; Kakefuda Y; Harunari T; Watabe H; Hiraya D; Akiyama D; Abe D; Takeyasu N; Aonuma K
    J Cardiol; 2015 Nov; 66(5):417-22. PubMed ID: 25623482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
    Maioli M; Toso A; Leoncini M; Micheletti C; Bellandi F
    Circ Cardiovasc Interv; 2011 Oct; 4(5):456-62. PubMed ID: 21972403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Park SH; Jeong MH; Park IH; Choi JS; Rhee JA; Kim IS; Kim MC; Cho JY; Sim DS; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2016 Jun; 212():100-6. PubMed ID: 27045874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions.
    Ko DT; Wijeysundera HC; Yun L; Austin PC; Cantor WJ; Tu JV
    Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):459-66. PubMed ID: 21712520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
    Zhang L; Zhang L; Lu Y; Wu B; Zhang S; Jiang H; Ge J; Chen H
    Int J Clin Pract; 2011 May; 65(5):624-30. PubMed ID: 21489086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.